The Africa IVD Market is expected to reach $1.49 billion by 2030, at a CAGR of 2.8% from 2023 to 2030. In vitro diagnostics (IVD) are tests performed on samples of blood or tissue taken from the human body to detect a wide range of diseases. These tests are used for preventing and treating various diseases. IVD test kits are generally used by hospital labs, private labs, government bodies, long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories to detect a wide range of diseases. The Africa IVD market covers various IVD tests based on technologies such as immunoassay, whole blood glucose monitoring, molecular diagnostics, point of care, clinical chemistry, hematology, coagulation & hemostasis, critical care, and urinalysis.
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/africa-ivd-market-5415

The Africa IVD market is segmented based on Product Category (Reagents, & Kits, Instruments, and Software & Services), Technology (Molecular Diagnostics, Point-of-Care Diagnostics, Immunoassay/Immunochemistry, Biochemistry/Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Microbiology, Coagulation & Hemostasis, and Other IVD Technologies), Application (Infectious Diseases, Oncology, Diabetes, Cardiology, Nephrology, Autoimmune Disorders, and Other Applications), Diagnostic Approach (Lab Testing, Point-of-care Testing, and OTC/Self-testing), and End User (Hospitals & Clinics, Diagnostic Laboratories, Home Healthcare, and Other End Users), and Geography. The study also evaluates industry competitors and analyzes their market shares.
Download Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5415
Reagents & Kits Generated the Larger Proportion of Revenue Compared to Instruments, Software & Services
In 2023, the reagents & kits segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is primarily attributed to the frequent use of assays & kits in the detection of various chronic diseases, the commercial availability of a diverse range of reagents & consumables for the diagnosis of various diseases, and the increase in the volume of testing for the infectious diseases, such as COVID-19 and influenza
Based on Technology, in 2023, the Molecular Diagnostics Segment Dominated the Market
In 2023, the molecular diagnostics segment is expected to account for the largest share of the Africa IVD market. The high prevalence of infectious diseases and rising penetration of advanced molecular techniques are expected to fuel market growth.
Based on Diagnostic Approach, in 2023, the Lab Testing Segment Registered Largest Share in the Africa IVD Market
In 2023, the lab testing segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the availability of several IVD tests and the higher accuracy of laboratory testing.


Based on Application, 2023, the Infectious Diseases Segment Registered Largest Share in the Africa IVD Market
In 2023, the infectious diseases segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the high prevalence of infectious diseases such as COVID-19, dengue, HIV, and Chagas disease in the region, the increased awareness about diagnostic testing, and the wide availability of COVID-19 test kits across the region.
Based on End User, in 2023, the Hospitals & Clinics Segment Generated the Largest Proportion of Revenue
In 2023, the hospitals & clinics segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the high demand for IVD diagnostics and the rising initiatives to support diagnostic testing in hospitals.
Request for Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5415
Geographic Review
This research report analyzes the market across major African countries and provides a comprehensive analysis of South Africa, Algeria, Nigeria, Kenya, Morocco, Tunisia, Tanzania, Egypt, and the rest of Africa.
Key Players
Key companies operating in the Africa IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).
Customize Report: https://www.meticulousresearch.com/request-customization/cp_id=5415
Scope of the Report
Africa IVD Market Assessment, by Product Category
• Reagents & Kits
• Instruments
• Software & Services
Africa IVD Market Assessment, by Technology
• Molecular Diagnostics
• Point-of-care Diagnostics
• Immunoassay/Immunochemistry
• Biochemistry/Clinical Chemistry
• Whole Blood Glucose Monitoring
• Hematology
• Microbiology
• Coagulation & Hemostasis
• Other IVD Technologies
(Note: Other technologies include urinalysis, hybridization, and loop-mediated amplification.)
Africa IVD Market Assessment, by Application
• Infectious Diseases
• Oncology
• Diabetes
• Cardiology
• Nephrology
• Autoimmune Disorders
• Other Applications
(Note: Other applications include toxicology, gastroenterology, neonatal, genetic, and neurological disorders.)
Africa IVD Market Assessment, by Diagnostic Approach
• Lab Testing
• Point-of-care Testing
• OTC/Self-testing
Africa IVD Market Assessment, by End User
• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care
• Other End Users
(Note: Other end users include long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories.)
Africa IVD Market Assessment, by Country
• South Africa
• Egypt
• Algeria
• Nigeria
• Morocco
• Kenya
• Tunisia
• Tanzania
• Rest of Africa

Buy Now: https://www.meticulousresearch.com/Checkout/47708335

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research